TickerFacts.

Scienture Holdings, Inc. (SCNX): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2015-12-31, 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$6.66M
As of 2025-12-31
$8.19M
As of 2026-06-30
+82.6%
3-year compound annual growth
2013-12-31: $84.3K2014-12-31: $705.6K2015-12-31: $78.7K2016-12-31: $14.7K2017-12-31: $183.9K2018-12-31: $869.6K2019-12-31: $2.87M2020-12-31: $5.92M2021-12-31: $3.12M2022-12-31: $1.09M2023-12-31: $151.9K2025-12-31: $6.66M$6.66M
2013-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$6.66Mn/a2026-03-30, Balance as of period end
No annual figure between 2023-12-31 and 2025-12-31.
2023-12-31$151.9K-86.1%2024-04-22, Balance as of period end
2022-12-31$1.09Mn/c2024-04-22, Balance as of period end
2021-12-31$3.12M-47.2%2023-03-27, Balance as of period end
2020-12-31$5.92M+106.1%2022-03-28, Balance as of period end
2019-12-31$2.87M+230.2%2021-03-29, Balance as of period end
2018-12-31$869.6K+372.8%2020-03-30, Balance as of period end
2017-12-31$183.9Kn/m2018-03-02, Balance as of period end
2016-12-31$14.7K-81.4%2018-03-02, Balance as of period end
2015-12-31$78.7Kn/c2017-03-30, Balance as of period end
2014-12-31$705.6K+736.8%2016-03-28, Balance as of period end
2013-12-31$84.3Kn/a2015-03-23, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Scienture Holdings, Inc. (SCNX)2025-12-31$6.66Mn/a
Medicinova Inc (MNOV)2025-12-31$30.81M-23.7%
Can-Fite BioPharma Ltd. (CANF)2025-12-31$5.53M+14.6%
Mereo BioPharma Group plc (MREO)2025-12-31$40.99M-41.3%
Lipella Pharmaceuticals Inc. (LIPO)2024-12-31$2.18M-33.7%
Provectus Biopharmaceuticals, Inc. (PVCT)2025-12-31$251.3K-18.3%
Silence Therapeutics plc (SLN)2025-12-31$11.28M-90.7%
Yarrow Bioscience, Inc. (YARW)2025-12-31$24.03M+20.6%
Allarity Therapeutics, Inc. (ALLR)2025-12-31$14.69M-24.8%

Compare SCNX, MNOV, CANF, MREO side by side · Screen every company in Pharmaceutical Preparations ↗